InsidersTradesSigma
Track the ST万邦 share price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, ST万邦 has published 2 public disclosures. Market capitalisation: €5.5bn. The latest transaction was disclosed on 13 October 2025 (Sale). Among the most active insiders: 庄惠. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
ST万邦 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se especializa en el desarrollo y comercialización de productos farmacéuticos.